tert-Butyl isopropyl(5-(1-isopropylpyrrolidin-2-yl)pyridin-2-yl)carbamate

Catalog No. :
ACGYQK361
CAS No. :
1352501-47-3
Molecular Formula :
C20H33N3O2
Molecular Weight :
347.50

IUPAC Name:tert-butyl isopropyl(5-(1-isopropylpyrrolidin-2-yl)pyridin-2-yl)carbamate

tert-Butyl isopropyl(5-(1-isopropylpyrrolidin-2-yl)pyridin-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$644.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl isopropyl(5-(1-isopropylpyrrolidin-2-yl)pyridin-2-yl)carbamate
IUPAC Nametert-butyl isopropyl(5-(1-isopropylpyrrolidin-2-yl)pyridin-2-yl)carbamate
Molecular FormulaC20H33N3O2
Molecular Weight347.50
SMILESO=C(OC(C)(C)C)N(C(C)C)C1=NC=C(C2N(C(C)C)CCC2)C=C1
InChI KeyXTBLHYOCGLBWKN-UHFFFAOYSA-N
SynonymIsopropyl-[5-(1-isopropyl-pyrrolidin-2-yl)-pyridin-2-yl]-carbamic acid tert-butyl ester;Carbamic acid, N-(1-methylethyl)-N-[5-[1-(1-methylethyl)-2-pyrrolidinyl]-2-pyridinyl]-, 1,1-dimethylethyl ester
CAS No.1352501-47-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGYQK361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGYQK361 route product structure diagram
    ACGYQK3611352501-47-3
Inquiry

2. ACGYQK361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGYQK361 route product structure diagram
    ACGYQK3611352501-47-3
Inquiry

Comments (0)